Literature DB >> 18363767

In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.

Y Mizukawa1, Y Yamazaki, T Shiohara.   

Abstract

BACKGROUND: Although a severe form of fixed drug eruption (FDE) clinically and histologically mimics toxic epidermal necrolysis (TEN), subsequent evolution of the two conditions is quite different. It remains unknown, however, which factors determine whether these lesions resolve spontaneously or subsequently progress to TEN.
OBJECTIVES: Because epidermal injury in TEN can be locally reproduced in the evolving FDE lesions, we sought to investigate how epidermal damage can be induced in the evolving FDE lesions and how disease progression to TEN can be prevented, by analysing the FDE lesions induced by clinical challenge with the causative drug.
METHODS: We immunohistochemically investigated in vivo dynamics of T-cell trafficking and activation that occur in the evolving FDE lesions using sequential biopsy specimens obtained at multiple time points from the FDE lesions.
RESULTS: Intraepidermal CD8+ T cells, which are resident in the lesional epidermis as a stable homogeneous population of memory T cells, transiently acquire a natural killer-like phenotype and express cytotoxic granules upon activation. The influx into the epidermis of CD4+ T cells including Foxp3+ regulatory T cells (Tregs) during the evolution serves to ameliorate epidermal damage induced by activation of the intraepidermal CD8+ T cells. Interleukin-15 derived from the lesional epidermis could maintain the survival of the intraepidermal CD8+ T cells even in the absence of antigenic stimulus over a prolonged period of time (> 4 years).
CONCLUSIONS: Whether Tregs could migrate to the lesions upon activation of intraepidermal CD8+ T cells would determine whether the inflammation becomes resolved spontaneously or progresses to TEN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363767     DOI: 10.1111/j.1365-2133.2008.08516.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

Review 1.  Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Authors:  Yoshiko Mizukawa; Tetsuo Shiohara
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

2.  Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis.

Authors:  Uwe Wollina; Leonore Unger
Journal:  J Dermatol Case Rep       Date:  2008-12-27

3.  Sulfur mustard induces immune sensitization in hairless guinea pigs.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; Thomas March; Waylon Weber; Janet Benson; Richard Jaramillo; Jean-Clare Seagrave; Gregory Schultz; Gary Grotendorst; Mohan Sopori
Journal:  Int Immunopharmacol       Date:  2009-11-01       Impact factor: 4.932

4.  The pulmonary localization of virus-specific T lymphocytes is governed by the tissue tropism of infection.

Authors:  Cory J Knudson; Kayla A Weiss; Stacey M Hartwig; Steven M Varga
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 5.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders.

Authors:  Ling Chen; Zhu Shen
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 6.  Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.

Authors:  Katherine C Konvinse; Elizabeth J Phillips; Katie D White; Jason A Trubiano
Journal:  Curr Opin Infect Dis       Date:  2016-12       Impact factor: 4.915

Review 7.  Pathophysiology of Skin Resident Memory T Cells.

Authors:  Yoshiki Tokura; Pawit Phadungsaksawasdi; Kazuo Kurihara; Toshiharu Fujiyama; Tetsuya Honda
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

8.  Local immunity by tissue-resident CD8(+) memory T cells.

Authors:  Thomas Gebhardt; Laura K Mackay
Journal:  Front Immunol       Date:  2012-11-09       Impact factor: 7.561

9.  Immunologic evaluation of drug allergy.

Authors:  Enrique Gómez; Maria Jose Torres; Cristobalina Mayorga; Miguel Blanca
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-30       Impact factor: 5.764

Review 10.  Drug allergy: causes and desensitization.

Authors:  Richard Warrington
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.